
### [MONDO:0004643](http://purl.obolibrary.org/obo/MONDO_0004643)
**Label:** myeloid leukemia

**Subclasses:** [MONDO:0020526](http://purl.obolibrary.org/obo/MONDO_0020526) (acute megakaryoblastic leukemia in down syndrome), [MONDO:0019458](http://purl.obolibrary.org/obo/MONDO_0019458) (acute basophilic leukemia), [MONDO:0019456](http://purl.obolibrary.org/obo/MONDO_0019456) (acute myeloid leukemia with multilineage dysplasia), [MONDO:0017893](http://purl.obolibrary.org/obo/MONDO_0017893) (inherited acute myeloid leukemia), [MONDO:0018004](http://purl.obolibrary.org/obo/MONDO_0018004) (acute megakaryoblastic leukemia without down syndrome), [MONDO:0012883](http://purl.obolibrary.org/obo/MONDO_0012883) (acute promyelocytic leukemia), [MONDO:0019457](http://purl.obolibrary.org/obo/MONDO_0019457) (therapy related acute myeloid leukemia and myelodysplastic syndrome), [MONDO:0017894](http://purl.obolibrary.org/obo/MONDO_0017894) (acute myeloid leukemia with CEBPA somatic mutations), [MONDO:0019455](http://purl.obolibrary.org/obo/MONDO_0019455) (acute panmyelosis with myelofibrosis), [MONDO:0020320](http://purl.obolibrary.org/obo/MONDO_0020320) (acute myeloblastic leukemia with maturation), [MONDO:0020321](http://purl.obolibrary.org/obo/MONDO_0020321) (acute undifferentiated leukemia), [MONDO:0020322](http://purl.obolibrary.org/obo/MONDO_0020322) (acute biphenotypic leukemia), [MONDO:0004614](http://purl.obolibrary.org/obo/MONDO_0004614) (chronic monocytic leukemia), [MONDO:0000875](http://purl.obolibrary.org/obo/MONDO_0000875) (adult acute monocytic leukemia), [MONDO:0004996](http://purl.obolibrary.org/obo/MONDO_0004996) (childhood acute myeloid leukemia), [MONDO:0005224](http://purl.obolibrary.org/obo/MONDO_0005224) (acute myeloblastic leukemia without maturation), [MONDO:0006237](http://purl.obolibrary.org/obo/MONDO_0006237) (granulocytic sarcoma), [MONDO:0004653](http://purl.obolibrary.org/obo/MONDO_0004653) (subacute myeloid leukemia), [MONDO:0005223](http://purl.obolibrary.org/obo/MONDO_0005223) (minimally differentiated acute myeloblastic leukemia), [MONDO:0010809](http://purl.obolibrary.org/obo/MONDO_0010809) (familial chronic myelocytic leukemia-like syndrome), [MONDO:0011996](http://purl.obolibrary.org/obo/MONDO_0011996) (chronic myelogenous leukemia), [MONDO:0004051](http://purl.obolibrary.org/obo/MONDO_0004051) (aleukemic monocytic leukemia cutis), [MONDO:0011118](http://purl.obolibrary.org/obo/MONDO_0011118) (bilineal acute myeloid leukemia), [MONDO:0017858](http://purl.obolibrary.org/obo/MONDO_0017858) (acute erythroid leukemia), [MONDO:0020317](http://purl.obolibrary.org/obo/MONDO_0020317) (acute myeloid leukemia with 11q23 abnormalities), [MONDO:0018437](http://purl.obolibrary.org/obo/MONDO_0018437) (acute myeloid leukemia with NPM1 somatic mutations), [MONDO:0020318](http://purl.obolibrary.org/obo/MONDO_0020318) (acute myeloid leukemia with minimal differentiation), [MONDO:0018435](http://purl.obolibrary.org/obo/MONDO_0018435) (acute myeloid leukemia with inv3(p21;q26.2) or t(3;3)(p21;q26.2)), [MONDO:0018436](http://purl.obolibrary.org/obo/MONDO_0018436) (megakaryoblastic acute myeloid leukemia with t(1;22)(p13;q13)), [MONDO:0018433](http://purl.obolibrary.org/obo/MONDO_0018433) (acute myeloid leukemia with t(6;9)(p23;q34)), [MONDO:0015164](http://purl.obolibrary.org/obo/MONDO_0015164) (acute myeloid leukemia and myelodysplastic syndromes related to alkylating agent), [MONDO:0018434](http://purl.obolibrary.org/obo/MONDO_0018434) (acute myeloid leukemia with t(9;11)(p22;q23)), [MONDO:0018874](http://purl.obolibrary.org/obo/MONDO_0018874) (acute myeloid leukemia), [MONDO:0015165](http://purl.obolibrary.org/obo/MONDO_0015165) (acute myeloid leukemia and myelodysplastic syndromes related to topoisomerase type 2 inhibitor), [MONDO:0015166](http://purl.obolibrary.org/obo/MONDO_0015166) (acute myeloid leukemia with t(8;21)(q22;q22) translocation), [MONDO:0018871](http://purl.obolibrary.org/obo/MONDO_0018871) (acute myelomonocytic leukemia M4), [MONDO:0018872](http://purl.obolibrary.org/obo/MONDO_0018872) (acute megakaryoblastic leukemia), [MONDO:0018256](http://purl.obolibrary.org/obo/MONDO_0018256) (acute myeloid leukemia with t(8;16)(p11;p13) translocation), [MONDO:0020078](http://purl.obolibrary.org/obo/MONDO_0020078) (acute myeloid leukemia with recurrent genetic anomaly), [MONDO:0019460](http://purl.obolibrary.org/obo/MONDO_0019460) (acute leukemia of ambiguous lineage), [MONDO:0020316](http://purl.obolibrary.org/obo/MONDO_0020316) (acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22)), [MONDO:0004600](http://purl.obolibrary.org/obo/MONDO_0004600) (monocytic leukemia), [MONDO:0004644](http://purl.obolibrary.org/obo/MONDO_0004644) (subacute monocytic leukemia), [MONDO:0007896](http://purl.obolibrary.org/obo/MONDO_0007896) (acute monocytic leukemia), [MONDO:0006861](http://purl.obolibrary.org/obo/MONDO_0006861) (myeloid sarcoma), [MONDO:0007573](http://purl.obolibrary.org/obo/MONDO_0007573) (acute erythroleukemia, familial), [MONDO:0015608](http://purl.obolibrary.org/obo/MONDO_0015608) (acute myeloid leukemia and myelodysplastic syndromes related to radiation), [MONDO:0015667](http://purl.obolibrary.org/obo/MONDO_0015667) (unclassified acute myeloid leukemia), 

**Mapped go classes:** [GO:0014069](http://purl.obolibrary.org/obo/GO_0014069) (postsynaptic density), [GO:0014068](http://purl.obolibrary.org/obo/GO_0014068) (positive regulation of phosphatidylinositol 3-kinase signaling), [GO:0008584](http://purl.obolibrary.org/obo/GO_0008584) (male gonad development), [GO:0000977](http://purl.obolibrary.org/obo/GO_0000977) (RNA polymerase II regulatory region sequence-specific DNA binding), [GO:0051092](http://purl.obolibrary.org/obo/GO_0051092) (positive regulation of NF-kappaB transcription factor activity), [GO:0030425](http://purl.obolibrary.org/obo/GO_0030425) (dendrite), [GO:0045892](http://purl.obolibrary.org/obo/GO_0045892) (negative regulation of transcription, DNA-templated), [GO:0051000](http://purl.obolibrary.org/obo/GO_0051000) (positive regulation of nitric-oxide synthase activity), [GO:0045893](http://purl.obolibrary.org/obo/GO_0045893) (positive regulation of transcription, DNA-templated), [GO:0046982](http://purl.obolibrary.org/obo/GO_0046982) (protein heterodimerization activity), [GO:0019003](http://purl.obolibrary.org/obo/GO_0019003) (GDP binding), [GO:0019002](http://purl.obolibrary.org/obo/GO_0019002) (GMP binding), [GO:0031234](http://purl.obolibrary.org/obo/GO_0031234) (extrinsic component of cytoplasmic side of plasma membrane), [GO:0032689](http://purl.obolibrary.org/obo/GO_0032689) (negative regulation of interferon-gamma production), [GO:0032720](http://purl.obolibrary.org/obo/GO_0032720) (negative regulation of tumor necrosis factor production), [GO:0035556](http://purl.obolibrary.org/obo/GO_0035556) (intracellular signal transduction), [GO:0019904](http://purl.obolibrary.org/obo/GO_0019904) (protein domain specific binding), [GO:0042826](http://purl.obolibrary.org/obo/GO_0042826) (histone deacetylase binding), [GO:0060591](http://purl.obolibrary.org/obo/GO_0060591) (chondroblast differentiation), [GO:0031076](http://purl.obolibrary.org/obo/GO_0031076) (embryonic camera-type eye development), [GO:0050728](http://purl.obolibrary.org/obo/GO_0050728) (negative regulation of inflammatory response), [GO:0005085](http://purl.obolibrary.org/obo/GO_0005085) (guanyl-nucleotide exchange factor activity), [GO:0065002](http://purl.obolibrary.org/obo/GO_0065002) (intracellular protein transmembrane transport), [GO:0000900](http://purl.obolibrary.org/obo/GO_0000900) (translation repressor activity, nucleic acid binding), [GO:0048008](http://purl.obolibrary.org/obo/GO_0048008) (platelet-derived growth factor receptor signaling pathway), [GO:0043114](http://purl.obolibrary.org/obo/GO_0043114) (regulation of vascular permeability), [GO:0007265](http://purl.obolibrary.org/obo/GO_0007265) (Ras protein signal transduction), [GO:0044323](http://purl.obolibrary.org/obo/GO_0044323) (retinoic acid-responsive element binding), [GO:0005089](http://purl.obolibrary.org/obo/GO_0005089) (Rho guanyl-nucleotide exchange factor activity), [GO:0043234](http://purl.obolibrary.org/obo/GO_0043234) (protein complex), [GO:0007420](http://purl.obolibrary.org/obo/GO_0007420) (brain development), [GO:0004674](http://purl.obolibrary.org/obo/GO_0004674) (protein serine/threonine kinase activity), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0005876](http://purl.obolibrary.org/obo/GO_0005876) (spindle microtubule), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0051099](http://purl.obolibrary.org/obo/GO_0051099) (positive regulation of binding), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0035701](http://purl.obolibrary.org/obo/GO_0035701) (hematopoietic stem cell migration), [GO:0051897](http://purl.obolibrary.org/obo/GO_0051897) (positive regulation of protein kinase B signaling), [GO:0051018](http://purl.obolibrary.org/obo/GO_0051018) (protein kinase A binding), [GO:0035264](http://purl.obolibrary.org/obo/GO_0035264) (multicellular organism growth), [GO:0043406](http://purl.obolibrary.org/obo/GO_0043406) (positive regulation of MAP kinase activity), [GO:0035022](http://purl.obolibrary.org/obo/GO_0035022) (positive regulation of Rac protein signal transduction), [GO:0035023](http://purl.obolibrary.org/obo/GO_0035023) (regulation of Rho protein signal transduction), [GO:0045947](http://purl.obolibrary.org/obo/GO_0045947) (negative regulation of translational initiation), [GO:0008285](http://purl.obolibrary.org/obo/GO_0008285) (negative regulation of cell proliferation), [GO:0030097](http://purl.obolibrary.org/obo/GO_0030097) (hemopoiesis), [GO:0008284](http://purl.obolibrary.org/obo/GO_0008284) (positive regulation of cell proliferation), [GO:0044212](http://purl.obolibrary.org/obo/GO_0044212) (transcription regulatory region DNA binding), [GO:0045787](http://purl.obolibrary.org/obo/GO_0045787) (positive regulation of cell cycle), [GO:0045666](http://purl.obolibrary.org/obo/GO_0045666) (positive regulation of neuron differentiation), [GO:0051393](http://purl.obolibrary.org/obo/GO_0051393) (alpha-actinin binding), [GO:0021897](http://purl.obolibrary.org/obo/GO_0021897) (forebrain astrocyte development), [GO:0045944](http://purl.obolibrary.org/obo/GO_0045944) (positive regulation of transcription by RNA polymerase II), [GO:0060268](http://purl.obolibrary.org/obo/GO_0060268) (negative regulation of respiratory burst), [GO:0043401](http://purl.obolibrary.org/obo/GO_0043401) (steroid hormone mediated signaling pathway), [GO:0043005](http://purl.obolibrary.org/obo/GO_0043005) (neuron projection), [GO:0002068](http://purl.obolibrary.org/obo/GO_0002068) (glandular epithelial cell development), [GO:0043524](http://purl.obolibrary.org/obo/GO_0043524) (negative regulation of neuron apoptotic process), [GO:0003148](http://purl.obolibrary.org/obo/GO_0003148) (outflow tract septum morphogenesis), [GO:0000166](http://purl.obolibrary.org/obo/GO_0000166) (nucleotide binding), [GO:0007507](http://purl.obolibrary.org/obo/GO_0007507) (heart development), [GO:0001012](http://purl.obolibrary.org/obo/GO_0001012) (RNA polymerase II regulatory region DNA binding), [GO:0003700](http://purl.obolibrary.org/obo/GO_0003700) (DNA binding transcription factor activity), [GO:0048384](http://purl.obolibrary.org/obo/GO_0048384) (retinoic acid receptor signaling pathway), [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome), [GO:0051146](http://purl.obolibrary.org/obo/GO_0051146) (striated muscle cell differentiation), [GO:0048027](http://purl.obolibrary.org/obo/GO_0048027) (mRNA 5'-UTR binding), [GO:0004879](http://purl.obolibrary.org/obo/GO_0004879) (nuclear receptor activity), [GO:0001889](http://purl.obolibrary.org/obo/GO_0001889) (liver development), [GO:0019221](http://purl.obolibrary.org/obo/GO_0019221) (cytokine-mediated signaling pathway), [GO:2000774](http://purl.obolibrary.org/obo/GO_2000774) (positive regulation of cellular senescence), [GO:0003707](http://purl.obolibrary.org/obo/GO_0003707) (steroid hormone receptor activity), [GO:0003708](http://purl.obolibrary.org/obo/GO_0003708) (retinoic acid receptor activity), [GO:2000378](http://purl.obolibrary.org/obo/GO_2000378) (negative regulation of reactive oxygen species metabolic process), [GO:0035014](http://purl.obolibrary.org/obo/GO_0035014) (phosphatidylinositol 3-kinase regulator activity), [GO:0038002](http://purl.obolibrary.org/obo/GO_0038002) (endocrine signaling), [GO:0060010](http://purl.obolibrary.org/obo/GO_0060010) (Sertoli cell fate commitment), [GO:0030917](http://purl.obolibrary.org/obo/GO_0030917) (midbrain-hindbrain boundary development), [GO:0048701](http://purl.obolibrary.org/obo/GO_0048701) (embryonic cranial skeleton morphogenesis), [GO:0071391](http://purl.obolibrary.org/obo/GO_0071391) (cellular response to estrogen stimulus), [GO:0005102](http://purl.obolibrary.org/obo/GO_0005102) (receptor binding), [GO:0060534](http://purl.obolibrary.org/obo/GO_0060534) (trachea cartilage development), [GO:0003677](http://purl.obolibrary.org/obo/GO_0003677) (DNA binding), [GO:0003713](http://purl.obolibrary.org/obo/GO_0003713) (transcription coactivator activity), [GO:0071300](http://purl.obolibrary.org/obo/GO_0071300) (cellular response to retinoic acid), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0001657](http://purl.obolibrary.org/obo/GO_0001657) (ureteric bud development), [GO:0003714](http://purl.obolibrary.org/obo/GO_0003714) (transcription corepressor activity), [GO:0005739](http://purl.obolibrary.org/obo/GO_0005739) (mitochondrion), [GO:0001934](http://purl.obolibrary.org/obo/GO_0001934) (positive regulation of protein phosphorylation), [GO:0032496](http://purl.obolibrary.org/obo/GO_0032496) (response to lipopolysaccharide), [GO:0016740](http://purl.obolibrary.org/obo/GO_0016740) (transferase activity), [GO:0060441](http://purl.obolibrary.org/obo/GO_0060441) (epithelial tube branching involved in lung morphogenesis), [GO:0008144](http://purl.obolibrary.org/obo/GO_0008144) (drug binding), [GO:0055012](http://purl.obolibrary.org/obo/GO_0055012) (ventricular cardiac muscle cell differentiation), [GO:0046777](http://purl.obolibrary.org/obo/GO_0046777) (protein autophosphorylation), [GO:0043422](http://purl.obolibrary.org/obo/GO_0043422) (protein kinase B binding), [GO:0000139](http://purl.obolibrary.org/obo/GO_0000139) (Golgi membrane), [GO:0008542](http://purl.obolibrary.org/obo/GO_0008542) (visual learning), [GO:0043025](http://purl.obolibrary.org/obo/GO_0043025) (neuronal cell body), [GO:0051171](http://purl.obolibrary.org/obo/GO_0051171) (regulation of nitrogen compound metabolic process), [GO:0045202](http://purl.obolibrary.org/obo/GO_0045202) (synapse), [GO:0060324](http://purl.obolibrary.org/obo/GO_0060324) (face development), [GO:0003014](http://purl.obolibrary.org/obo/GO_0003014) (renal system process), [GO:0032526](http://purl.obolibrary.org/obo/GO_0032526) (response to retinoic acid), [GO:0045211](http://purl.obolibrary.org/obo/GO_0045211) (postsynaptic membrane), [GO:0048169](http://purl.obolibrary.org/obo/GO_0048169) (regulation of long-term neuronal synaptic plasticity), [GO:0003924](http://purl.obolibrary.org/obo/GO_0003924) (GTPase activity), [GO:0048167](http://purl.obolibrary.org/obo/GO_0048167) (regulation of synaptic plasticity), [GO:0015629](http://purl.obolibrary.org/obo/GO_0015629) (actin cytoskeleton), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0051726](http://purl.obolibrary.org/obo/GO_0051726) (regulation of cell cycle), [GO:0033339](http://purl.obolibrary.org/obo/GO_0033339) (pectoral fin development), [GO:0032403](http://purl.obolibrary.org/obo/GO_0032403) (protein complex binding), [GO:0017148](http://purl.obolibrary.org/obo/GO_0017148) (negative regulation of translation), [GO:0030223](http://purl.obolibrary.org/obo/GO_0030223) (neutrophil differentiation), [GO:0008270](http://purl.obolibrary.org/obo/GO_0008270) (zinc ion binding), [GO:0043277](http://purl.obolibrary.org/obo/GO_0043277) (apoptotic cell clearance), [GO:0042981](http://purl.obolibrary.org/obo/GO_0042981) (regulation of apoptotic process), [GO:0002692](http://purl.obolibrary.org/obo/GO_0002692) (negative regulation of cellular extravasation), [GO:0043314](http://purl.obolibrary.org/obo/GO_0043314) (negative regulation of neutrophil degranulation), [GO:0060313](http://purl.obolibrary.org/obo/GO_0060313) (negative regulation of blood vessel remodeling), [GO:0002573](http://purl.obolibrary.org/obo/GO_0002573) (myeloid leukocyte differentiation), [GO:0010629](http://purl.obolibrary.org/obo/GO_0010629) (negative regulation of gene expression), [GO:0000790](http://purl.obolibrary.org/obo/GO_0000790) (nuclear chromatin), [GO:0003417](http://purl.obolibrary.org/obo/GO_0003417) (growth plate cartilage development), [GO:0010628](http://purl.obolibrary.org/obo/GO_0010628) (positive regulation of gene expression), [GO:0042472](http://purl.obolibrary.org/obo/GO_0042472) (inner ear morphogenesis), [GO:0030054](http://purl.obolibrary.org/obo/GO_0030054) (cell junction), [GO:0050766](http://purl.obolibrary.org/obo/GO_0050766) (positive regulation of phagocytosis), [GO:0030853](http://purl.obolibrary.org/obo/GO_0030853) (negative regulation of granulocyte differentiation), [GO:0032753](http://purl.obolibrary.org/obo/GO_0032753) (positive regulation of interleukin-4 production), [GO:0050885](http://purl.obolibrary.org/obo/GO_0050885) (neuromuscular process controlling balance), [GO:0030336](http://purl.obolibrary.org/obo/GO_0030336) (negative regulation of cell migration), [GO:0032754](http://purl.obolibrary.org/obo/GO_0032754) (positive regulation of interleukin-5 production), [GO:0030852](http://purl.obolibrary.org/obo/GO_0030852) (regulation of granulocyte differentiation), [GO:0061037](http://purl.obolibrary.org/obo/GO_0061037) (negative regulation of cartilage development), [GO:0005096](http://purl.obolibrary.org/obo/GO_0005096) (GTPase activator activity), [GO:0043565](http://purl.obolibrary.org/obo/GO_0043565) (sequence-specific DNA binding), [GO:0006468](http://purl.obolibrary.org/obo/GO_0006468) (protein phosphorylation), [GO:0021575](http://purl.obolibrary.org/obo/GO_0021575) (hindbrain morphogenesis), [GO:0060348](http://purl.obolibrary.org/obo/GO_0060348) (bone development), [GO:0000122](http://purl.obolibrary.org/obo/GO_0000122) (negative regulation of transcription by RNA polymerase II), [GO:0005525](http://purl.obolibrary.org/obo/GO_0005525) (GTP binding), [GO:0045471](http://purl.obolibrary.org/obo/GO_0045471) (response to ethanol), [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding), [GO:0001843](http://purl.obolibrary.org/obo/GO_0001843) (neural tube closure), [GO:0005925](http://purl.obolibrary.org/obo/GO_0005925) (focal adhesion), [GO:0045596](http://purl.obolibrary.org/obo/GO_0045596) (negative regulation of cell differentiation), [GO:0016310](http://purl.obolibrary.org/obo/GO_0016310) (phosphorylation), [GO:0032228](http://purl.obolibrary.org/obo/GO_0032228) (regulation of synaptic transmission, GABAergic), [GO:0007281](http://purl.obolibrary.org/obo/GO_0007281) (germ cell development), [GO:0031490](http://purl.obolibrary.org/obo/GO_0031490) (chromatin DNA binding), [GO:0042802](http://purl.obolibrary.org/obo/GO_0042802) (identical protein binding), [GO:0007165](http://purl.obolibrary.org/obo/GO_0007165) (signal transduction), [GO:0006351](http://purl.obolibrary.org/obo/GO_0006351) (transcription, DNA-templated), [GO:0060173](http://purl.obolibrary.org/obo/GO_0060173) (limb development), [GO:0007283](http://purl.obolibrary.org/obo/GO_0007283) (spermatogenesis), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0045630](http://purl.obolibrary.org/obo/GO_0045630) (positive regulation of T-helper 2 cell differentiation), [GO:0008134](http://purl.obolibrary.org/obo/GO_0008134) (transcription factor binding), [GO:0060215](http://purl.obolibrary.org/obo/GO_0060215) (primitive hemopoiesis), [GO:0060216](http://purl.obolibrary.org/obo/GO_0060216) (definitive hemopoiesis), [GO:0001972](http://purl.obolibrary.org/obo/GO_0001972) (retinoic acid binding), [GO:0032736](http://purl.obolibrary.org/obo/GO_0032736) (positive regulation of interleukin-13 production), [GO:0048471](http://purl.obolibrary.org/obo/GO_0048471) (perinuclear region of cytoplasm), [GO:0031647](http://purl.obolibrary.org/obo/GO_0031647) (regulation of protein stability), [GO:0071222](http://purl.obolibrary.org/obo/GO_0071222) (cellular response to lipopolysaccharide), [GO:0048873](http://purl.obolibrary.org/obo/GO_0048873) (homeostasis of number of cells within a tissue), [GO:0005938](http://purl.obolibrary.org/obo/GO_0005938) (cell cortex), [GO:0043066](http://purl.obolibrary.org/obo/GO_0043066) (negative regulation of apoptotic process), [GO:0048872](http://purl.obolibrary.org/obo/GO_0048872) (homeostasis of number of cells), [GO:0070374](http://purl.obolibrary.org/obo/GO_0070374) (positive regulation of ERK1 and ERK2 cascade), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0045121](http://purl.obolibrary.org/obo/GO_0045121) (membrane raft), [GO:0005819](http://purl.obolibrary.org/obo/GO_0005819) (spindle), [GO:0030275](http://purl.obolibrary.org/obo/GO_0030275) (LRR domain binding), [GO:0031641](http://purl.obolibrary.org/obo/GO_0031641) (regulation of myelination), [GO:0016301](http://purl.obolibrary.org/obo/GO_0016301) (kinase activity), [GO:0030036](http://purl.obolibrary.org/obo/GO_0030036) (actin cytoskeleton organization), [GO:0019899](http://purl.obolibrary.org/obo/GO_0019899) (enzyme binding), 

**Class expressions from DL-Learner:**

- Thing 54.95%
- [GO:0030097](http://purl.obolibrary.org/obo/GO_0030097) (hemopoiesis) 51.67%
- [GO:0060534](http://purl.obolibrary.org/obo/GO_0060534) (trachea cartilage development) 50.83%
- [GO:0060351](http://purl.obolibrary.org/obo/GO_0060351) (cartilage development involved in endochondral bone morphogenesis) 50.83%
- [GO:0060324](http://purl.obolibrary.org/obo/GO_0060324) (face development) 50.83%
- [GO:0060216](http://purl.obolibrary.org/obo/GO_0060216) (definitive hemopoiesis) 50.83%
- [GO:0060215](http://purl.obolibrary.org/obo/GO_0060215) (primitive hemopoiesis) 50.83%
- [GO:0060173](http://purl.obolibrary.org/obo/GO_0060173) (limb development) 50.83%
- [GO:0038002](http://purl.obolibrary.org/obo/GO_0038002) (endocrine signaling) 50.83%
- [GO:0035264](http://purl.obolibrary.org/obo/GO_0035264) (multicellular organism growth) 50.83%
- [GO:0035162](http://purl.obolibrary.org/obo/GO_0035162) (embryonic hemopoiesis) 50.83%
- [GO:0033339](http://purl.obolibrary.org/obo/GO_0033339) (pectoral fin development) 50.83%
- [GO:0031076](http://purl.obolibrary.org/obo/GO_0031076) (embryonic camera-type eye development) 50.83%
- [GO:0030917](http://purl.obolibrary.org/obo/GO_0030917) (midbrain-hindbrain boundary development) 50.83%
- [GO:0008584](http://purl.obolibrary.org/obo/GO_0008584) (male gonad development) 50.83%


